These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9972128)
1. Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro. Myers SA; Wolowacz RG Adv Dent Res; 1998 Nov; 12(2):86-93. PubMed ID: 9972128 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells. Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW J Periodontal Res; 2009 Apr; 44(2):266-74. PubMed ID: 18973523 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives. Grenier D; Plamondon P; Sorsa T; Lee HM; McNamara T; Ramamurthy NS; Golub LM; Teronen O; Mayrand D J Periodontol; 2002 Jan; 73(1):79-85. PubMed ID: 11846203 [TBL] [Abstract][Full Text] [Related]
5. Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis. Seftor EA; Seftor RE; Nieva DR; Hendrix MJ Adv Dent Res; 1998 Nov; 12(2):103-10. PubMed ID: 9972131 [No Abstract] [Full Text] [Related]
6. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Uitto VJ; Firth JD; Nip L; Golub LM Ann N Y Acad Sci; 1994 Sep; 732():140-51. PubMed ID: 7978787 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Hanemaaijer R; Visser H; Koolwijk P; Sorsa T; Salo T; Golub LM; van Hinsbergh VW Adv Dent Res; 1998 Nov; 12(2):114-8. PubMed ID: 9972133 [TBL] [Abstract][Full Text] [Related]
8. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells. Duivenvoorden WC; Hirte HW; Singh G Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290 [TBL] [Abstract][Full Text] [Related]
9. The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration. Mäkelä M; Sorsa T; Uitto VJ; Salo T; Teronen O; Larjava H Adv Dent Res; 1998 Nov; 12(2):131-5. PubMed ID: 9972137 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660 [TBL] [Abstract][Full Text] [Related]
11. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases. Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901 [TBL] [Abstract][Full Text] [Related]
13. Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells. Trachtman H; Futterweit S; Greenwald R; Moak S; Singhal P; Franki N; Amin AR Biochem Biophys Res Commun; 1996 Dec; 229(1):243-8. PubMed ID: 8954113 [TBL] [Abstract][Full Text] [Related]
14. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines. Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617 [TBL] [Abstract][Full Text] [Related]
16. Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels. Wong WR; Kossodo S; Kochevar IE J Formos Med Assoc; 2001 Jun; 100(6):377-82. PubMed ID: 11480246 [TBL] [Abstract][Full Text] [Related]
17. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts. Li L; Akers K; Eisen AZ; Seltzer JL Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808 [TBL] [Abstract][Full Text] [Related]